NuVasive Company Profile (NASDAQ:NUVA)

About NuVasive

NuVasive logoNuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company's spine surgery products line offerings include thoracolumbar product offerings, cervical product offerings, Intra-Operative Monitoring (IOM) services and disposables, which are used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company's biologics product line offerings includes allograft (donated human tissue), FormaGraft (a collagen synthetic product), Osteocel Plus and Osteocel Pro (each an allograft cellular matrix containing viable mesenchymal stem cells (MSCs)), and AttraX (a synthetic bone graft material), all of which are used to aid the spinal fusion or bone healing process.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NUVA
  • CUSIP: 67070410
Key Metrics:
  • Previous Close: $66.77
  • 50 Day Moving Average: $64.80
  • 200 Day Moving Average: $57.09
  • 52-Week Range: $50,214,000.00 - $36.81
  • Trailing P/E Ratio: 69.26
  • Foreward P/E Ratio: 32.10
  • P/E Growth: 2.52
  • Market Cap: $3.35B
  • Outstanding Shares: 50,214,000
  • Beta: 0.86
  • Net Margins: 5.28%
  • Return on Equity: 10.57%
  • Return on Assets: 5.07%
  • Debt-to-Equity Ratio: 0.78%
  • Current Ratio: 2.36%
  • Quick Ratio: 1.69%
Additional Links:
Companies Related to NuVasive:

Analyst Ratings

Consensus Ratings for NuVasive (NASDAQ:NUVA) (?)
Ratings Breakdown: 3 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.77)
Consensus Price Target: $64.92 (2.78% downside)

Analysts' Ratings History for NuVasive (NASDAQ:NUVA)
DateFirmActionRatingPrice TargetDetails
9/1/2016Piper Jaffray Cos.Reiterated RatingOverweight$70.00View Rating Details
8/3/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/27/2016Barclays PLCBoost Price TargetOverweight$63.00 -> $71.00View Rating Details
7/27/2016Brean CapitalBoost Price TargetBuy$60.00 -> $70.00View Rating Details
7/13/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$55.00 -> $74.00View Rating Details
6/6/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/7/2016Morgan StanleyReiterated RatingHold$57.00View Rating Details
5/10/2016Leerink SwannReiterated RatingBuy$65.00View Rating Details
4/27/2016Needham & Company LLCReiterated RatingHoldView Rating Details
4/27/2016Cowen and CompanyReiterated RatingBuy$52.00 -> $63.00View Rating Details
12/11/2015Bank of America Corp.UpgradeUnderperform -> Neutral$56.00View Rating Details
10/6/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$52.00 -> $64.00View Rating Details
10/5/2015Royal Bank Of CanadaReiterated RatingOutperform$58.00View Rating Details
7/29/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$48.00 -> $68.00View Rating Details
6/3/2015Goldman Sachs Group Inc.DowngradeBuy -> Neutral$52.00View Rating Details
1/13/2015WallachBeth CapitalBoost Price TargetBuy$49.00 -> $55.00View Rating Details
1/13/2015Robert W. BairdBoost Price TargetOutperform$50.00 -> $55.00View Rating Details
1/13/2015Summer StreetDowngradeBuy -> NeutralView Rating Details
11/17/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
(Data available from 9/25/2014 forward)


Earnings History for NuVasive (NASDAQ:NUVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q216$0.36$0.40$232.86 million$236.50 millionViewListenView Earnings Details
4/26/2016Q116$0.27$0.31$205.54 million$215.10 millionViewListenView Earnings Details
2/11/2016Q415$0.31$0.35$215.08 million$215.30 millionViewListenView Earnings Details
10/27/2015Q315$0.27$0.35$200.21 million$200.50 millionViewListenView Earnings Details
7/28/2015Q215$0.25$0.31$200.71 million$202.91 millionViewListenView Earnings Details
5/4/2015Q115$0.21$0.30$189.30 million$192.40 millionViewListenView Earnings Details
2/24/2015Q4$0.37$0.39$201.40 million$204.30 millionViewListenView Earnings Details
10/30/2014Q314$0.25$0.19$179.30 million$189.90 millionViewListenView Earnings Details
7/29/2014Q214$0.25$0.28$177.50 million$190.70 millionViewListenView Earnings Details
4/29/2014Q114$0.23$0.29$171.30 million$177.50 millionViewListenView Earnings Details
3/3/2014Q413$0.32$0.37$181.24 million$190.80 millionViewListenView Earnings Details
10/29/2013Q313$0.24$0.39$158.30 million$169.20 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.23$0.20$161.67 million$165.70 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.22$0.26$157.34 million$159.50 millionViewListenView Earnings Details
2/26/2013Q4 2012$0.21$0.34$156.35 million$165.80 millionViewListenView Earnings Details
10/24/2012$0.21$0.23ViewN/AView Earnings Details
7/25/2012$0.23$0.27ViewN/AView Earnings Details
4/30/2012$0.18$0.20ViewN/AView Earnings Details
2/22/2012$0.22$0.27ViewN/AView Earnings Details
10/27/2011$0.24$0.26ViewN/AView Earnings Details
7/25/2011$0.28$0.30ViewN/AView Earnings Details
5/5/2011$0.19$0.24ViewN/AView Earnings Details
2/23/2011$0.42$0.46ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NuVasive (NASDAQ:NUVA)
Current Year EPS Consensus Estimate: $1.65 EPS
Next Year EPS Consensus Estimate: $2.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.25$0.32$0.29
Q2 20166$0.33$0.39$0.37
Q3 20163$0.39$0.40$0.40
Q4 20163$0.42$0.52$0.48
Q1 20172$0.39$0.39$0.39
Q2 20172$0.48$0.50$0.49
Q3 20172$0.51$0.55$0.53
Q4 20172$0.65$0.66$0.66
(Data provided by Zacks Investment Research)


Dividend History for NuVasive (NASDAQ:NUVA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for NuVasive (NASDAQ:NUVA)
Insider Ownership Percentage: 4.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2016Jason HannonEVPSell2,625$64.80$170,100.00View SEC Filing  
8/2/2016Jason HannonEVPSell11,184$62.70$701,236.80View SEC Filing  
8/2/2016Lesley H. HoweDirectorSell3,602$62.44$224,908.88View SEC Filing  
7/20/2016Jason HannonEVPSell2,920$62.80$183,376.00View SEC Filing  
6/16/2016Jason HannonEVPSell14,534$57.57$836,722.38View SEC Filing  
1/6/2016Patrick MilesCOOSell10,723$54.03$579,363.69View SEC Filing  
12/16/2015Patrick MilesCOOSell9,127$52.56$479,715.12View SEC Filing  
12/7/2015Quentin S BlackfordCFOSell15,000$51.10$766,500.00View SEC Filing  
12/3/2015Patrick MilesCOOSell5,873$52.51$308,391.23View SEC Filing  
11/2/2015Patrick MilesCOOSell15,000$48.12$721,800.00View SEC Filing  
10/5/2015Matthew LinkinsiderSell1,714$50.72$86,934.08View SEC Filing  
10/3/2015Quentin S BlackfordCFOSell5,000$36.30$181,500.00View SEC Filing  
10/1/2015Patrick MilesCOOSell15,000$48.10$721,500.00View SEC Filing  
9/8/2015Russell PowersEVPSell5,806$51.64$299,821.84View SEC Filing  
9/2/2015Jason HannonEVPSell11,962$52.02$622,263.24View SEC Filing  
9/1/2015Patrick MilesCOOSell15,000$52.03$780,450.00View SEC Filing  
8/31/2015Patrick MilesCOOSell15,000$53.34$800,100.00View SEC Filing  
7/20/2015Jason HannonEVPSell15,000$49.60$744,000.00View SEC Filing  
6/15/2015Gregory T LucierCEOBuy4,491$49.49$222,259.59View SEC Filing  
6/12/2015Gregory T LucierCEOBuy8,000$50.10$400,800.00View SEC Filing  
6/10/2015Gregory T LucierCEOBuy10,000$49.10$491,000.00View SEC Filing  
6/8/2015Gregory T LucierCEOBuy10,000$49.26$492,600.00View SEC Filing  
6/4/2015Gregory T LucierCEOBuy10,000$49.71$497,100.00View SEC Filing  
6/2/2015Gregory T LucierCEOBuy8,000$49.96$399,680.00View SEC Filing  
6/2/2015Patrick MilesCOOSell4,194$49.47$207,477.18View SEC Filing  
5/29/2015Jack R BlairDirectorSell3,703$50.16$185,742.48View SEC Filing  
5/28/2015Gregory T LucierCEOBuy34,000$49.25$1,674,500.00View SEC Filing  
5/28/2015Russell PowersEVPSell8,042$49.00$394,058.00View SEC Filing  
5/19/2015Patrick MilesCOOSell15,000$47.52$712,800.00View SEC Filing  
5/1/2015Russell PowersEVPSell11,881$45.21$537,140.01View SEC Filing  
4/24/2015Russell PowersEVPSell3,888$44.07$171,344.16View SEC Filing  
3/13/2015Patrick MilesCOOSell7,920$45.52$360,518.40View SEC Filing  
3/9/2015Alexis V LukianovCEOSell5,313$44.82$238,128.66View SEC Filing  
3/3/2015Matthew LinkInsiderSell7,500$44.46$333,450.00View SEC Filing  
3/2/2015Jason HannonEVPSell5,085$45.06$229,130.10View SEC Filing  
2/9/2015Alexis V LukianovCEOSell5,454$46.10$251,429.40View SEC Filing  
2/5/2015Matthew LinkInsiderSell4,078$45.77$186,650.06View SEC Filing  
2/3/2015Patrick MilesCOOSell15,000$45.53$682,950.00View SEC Filing  
1/28/2015Keith ValentineCOOSell6,970$46.96$327,311.20View SEC Filing  
1/12/2015Alexis V LukianovCEOSell7,452$49.69$370,289.88View SEC Filing  
1/5/2015Jason HannonEVPSell12,117$46.82$567,317.94View SEC Filing  
1/5/2015Patrick MilesInsiderSell15,000$46.61$699,150.00View SEC Filing  
12/30/2014Jason HannonEVPSell15,000$47.63$714,450.00View SEC Filing  
12/29/2014Jason HannonEVPSell3,146$47.57$149,655.22View SEC Filing  
12/24/2014Patrick MilesInsiderSell15,000$47.52$712,800.00View SEC Filing  
12/19/2014Keith ValentineCOOSell5,893$47.78$281,567.54View SEC Filing  
12/1/2014Keith ValentineCOOSell2,500$43.66$109,150.00View SEC Filing  
11/19/2014Keith ValentineCOOSell5,582$43.32$241,812.24View SEC Filing  
11/19/2014Quentin S BlackfordCFOSell7,698$43.41$334,170.18View SEC Filing  
11/7/2014Alexis V LukianovCEOSell25,000$41.40$1,035,000.00View SEC Filing  
11/3/2014Keith ValentineCOOSell2,500$40.61$101,525.00View SEC Filing  
10/2/2014Keith ValentineCOOSell2,500$35.00$87,500.00View SEC Filing  
9/2/2014Keith ValentineCOOSell2,500$35.14$87,850.00View SEC Filing  
8/1/2014Keith ValentineCOOSell2,500$37.11$92,775.00View SEC Filing  
8/1/2014Michael LambertCFOSell4,010$37.11$148,811.10View SEC Filing  
7/30/2014Jason HannonEVPSell5,000$39.00$195,000.00View SEC Filing  
7/10/2014Russell PowersEVPSell3,200$33.43$106,976.00View SEC Filing  
7/1/2014Keith ValentineCOOSell2,500$35.65$89,125.00View SEC Filing  
7/1/2014Michael LambertCFOSell23,225$35.48$824,023.00View SEC Filing  
6/20/2014Keith ValentineCOOSell5,000$35.00$175,000.00View SEC Filing  
6/20/2014Russell PowersEVPSell9,526$35.00$333,410.00View SEC Filing  
5/5/2014Robert HuntDirectorSell20,000$34.25$685,000.00View SEC Filing  
5/2/2014Michael LambertCFOSell13,096$33.07$433,084.72View SEC Filing  
4/1/2014Keith ValentineCOOSell2,500$38.41$96,025.00View SEC Filing  
3/11/2014Peter FarrellDirectorSell48,000$36.88$1,770,240.00View SEC Filing  
1/21/2014Jason HannonEVPSell10,095$36.60$369,477.00View SEC Filing  
1/16/2014Keith ValentineCOOSell20,000$37.96$759,200.00View SEC Filing  
1/7/2014Alexis LukianovCEOSell34,217$34.29$1,173,300.93View SEC Filing  
1/7/2014Craig HunsakerSVPSell4,980$35.00$174,300.00View SEC Filing  
12/30/2013Craig HunsakerSVPSell4,275$32.10$137,227.50View SEC Filing  
12/23/2013Michael LambertCFOSell17,091$32.49$555,286.59View SEC Filing  
11/7/2013Alexis LukianovCEOSell5,000$31.45$157,250.00View SEC Filing  
10/30/2013Jason HannonEVPSell2,334$28.90$67,452.60View SEC Filing  
10/30/2013Patrick MilesInsiderSell21,223$31.10$660,035.30View SEC Filing  
10/28/2013Patrick MilesInsiderSell7,331$25.72$188,553.32View SEC Filing  
10/21/2013Russell PowersVPSell12,500$25.39$317,375.00View SEC Filing  
10/11/2013Jason HannonEVPSell1,000$26.00$26,000.00View SEC Filing  
10/7/2013Jason HannonEVPSell8,705$23.99$208,832.95View SEC Filing  
10/7/2013Michael LambertCFOSell15,442$24.04$371,225.68View SEC Filing  
8/6/2013Richard Treharne IIIDirectorBuy2,000$23.26$46,520.00View SEC Filing  
7/12/2013Craig E HunsakerSVPSell2,000$27.00$54,000.00View SEC Filing  
7/8/2013Alexis V LukianovCEOSell5,000$25.74$128,700.00View SEC Filing  
7/1/2013Keith ValentineCOOSell1,698$25.00$42,450.00View SEC Filing  
5/13/2013Alexis V LukianovCEOSell7,500$22.71$170,325.00View SEC Filing  
5/8/2013Peter Michael LeddyDirectorBuy2,400$22.24$53,376.00View SEC Filing  
5/7/2013Alexis V LukianovCEOSell12,500$22.11$276,375.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for NuVasive (NASDAQ:NUVA)
News IconNoteworthy Analyst Ratings of Two Stocks NuVasive, Inc. (NASDAQ:NUVA), Spirit AeroSystems Holdings, Inc. (NYSE ... - The Voice Registrar (NASDAQ:NUVA) - September 24 at 10:53 AM
News IconTrader's Round Up – NuVasive, Inc.'s (NUVA) - Hot Stocks Point (NASDAQ:NUVA) - September 23 at 6:01 PM
News IconAverage Price Target for NuVasive, Inc. (NASDAQ:NUVA) is $70.92 - Newburgh Press (NASDAQ:NUVA) - September 23 at 6:01 PM logoBecton (BDX) to Expand Syringe Capacity at Holdrege Facility (NASDAQ:NUVA) - September 23 at 11:10 AM logoNuVasive Shares Up 53.8% Since SmarTrend's Buy Recommendation (NUVA) (NASDAQ:NUVA) - September 21 at 10:37 AM
News IconThe Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory ... (NASDAQ:NUVA) - September 21 at 10:37 AM logoZimmer Biomet Introduces Vanguard Individualized Design (NASDAQ:NUVA) - September 21 at 10:37 AM logoNuVasive (NUVA) Announces FDA 510(k) Clearance for MAGEC System (NASDAQ:NUVA) - September 20 at 11:46 AM
News IconFDA approves Nuvasive’s Reline system for Magec spine implants (NASDAQ:NUVA) - September 20 at 11:46 AM logoBoston Scientific's LOTUS Edge Valve System Gets CE Mark (NASDAQ:NUVA) - September 20 at 11:46 AM logoNuVasive Receives FDA 510(k) Clearance Reinforcing ... - Marketwired (press release) (NASDAQ:NUVA) - September 19 at 6:30 PM logoNuVasive Receives FDA 510(k) Clearance Reinforcing Comprehensive Portfolio Supporting Pediatric, Adolescent and Adult Spinal Deformity Patients (NASDAQ:NUVA) - September 19 at 10:58 AM logoBRIEF-NuVasive receives FDA 510(k)clearance (NASDAQ:NUVA) - September 19 at 7:40 AM logoCepheid Announces Expansion of Molecular C. Difficile Product (NASDAQ:NUVA) - September 16 at 10:00 AM logoNuVasive Has Returned 49.4% Since SmarTrend Recommendation (NUVA) (NASDAQ:NUVA) - September 14 at 10:47 AM logoPerrenial Target and Acquirer NuVasive Names New President and COO (NASDAQ:NUVA) - September 14 at 10:47 AM logoNuVasive : Expanding local company announces leadership changes (NASDAQ:NUVA) - September 13 at 11:22 AM
News IconJason M. Hannon and Patrick S. Miles (NASDAQ:NUVA) - September 13 at 11:22 AM
News IconExpanding local company announces leadership changes (NASDAQ:NUVA) - September 12 at 6:11 PM
News IconJason M. Hannon Named President/COO at NuVasive Inc. (NASDAQ:NUVA) - September 12 at 6:11 PM logo4:07 pm NuVasive promotes Jason Hannon to succeed Patrick Miles as COO, Patrick Miles appointed Vice Chairman; reaffirms FY16 guidance (NASDAQ:NUVA) - September 12 at 6:11 PM logoNUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State (NASDAQ:NUVA) - September 12 at 6:11 PM logoNuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman (NASDAQ:NUVA) - September 12 at 6:11 PM
News IconGlobal Autografts Market Research Report 2016: Zimmer Biomet Holdings, Inc. (USA), Exactech, Inc. (USA) (NASDAQ:NUVA) - September 9 at 11:10 AM
News IconSpinal Stenosis Market Analysis and Value Forecast Snapshot by End-use Industry 2016-2026 (NASDAQ:NUVA) - September 8 at 6:16 PM logoAngioDynamics (ANGO) Hits 52-Week High on Positive View (NASDAQ:NUVA) - September 8 at 10:19 AM
News IconShares Spotted Rising Up to a Recent High: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - September 7 at 6:40 PM
News IconTrading Update: Following Activity of NuVasive, Inc. (NASDAQ:NUVA) Shares During the Current Session - Post News (NASDAQ:NUVA) - September 7 at 6:40 PM
News IconNuVasive’s MAGEC System Featured in Live Surgery Event at the Spine Hospital at NewYork-Presbyterian (NASDAQ:NUVA) - September 6 at 6:41 PM logoNuVasive's MAGEC System Featured in Live Surgery Event at the Spine Hospital at NewYork-Presbyterian (NASDAQ:NUVA) - September 6 at 11:14 AM featured highlights: Corcept Therapeutics, Parsley Energy, TRI Pointe Group, NuVasive and Facebook (NASDAQ:NUVA) - September 6 at 11:14 AM logoNuVasive to Participate in Investor Events in September 2016 (NASDAQ:NUVA) - September 2 at 11:22 AM logoETF’s with exposure to NuVasive, Inc. : September 2, 2016 (NASDAQ:NUVA) - September 2 at 11:22 AM
News IconStock Tracking Up to a Recent High: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - September 1 at 9:41 AM
News IconShare Insight: Earnings Recap and Price Target Review for NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 31 at 11:32 AM
News IconShares Marching Up to a Recent High: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 30 at 6:30 PM
News IconCrowd Sentiment & Brokerage Firm Views on NuVasive, Inc. (NASDAQ:NUVA)? - Post News (NASDAQ:NUVA) - August 30 at 9:50 AM
News IconStock Up Over the Past Five Trading Days: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 30 at 9:50 AM logoUptrend Call Working As NuVasive Stock Rises 45.1% (NUVA) (NASDAQ:NUVA) - August 26 at 6:17 PM logoBioTelemetry Forms Partnership with Bloomlife, Stock Down (NASDAQ:NUVA) - August 24 at 9:40 AM
News IconStock Trading Above Moving Averages: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 22 at 6:31 PM
News IconStock Gaining Over the Past Six Months: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 22 at 11:06 AM logoAkers Biosciences OxiCheck Study Results Positive, Stock Up (NASDAQ:NUVA) - August 22 at 11:06 AM logoShares of NUVA Up 44.8% Since Uptrend Call on Shares (NASDAQ:NUVA) - August 19 at 9:35 AM logoNuVasive Up 44.1% Since SmarTrend Uptrend Call (NUVA) (NASDAQ:NUVA) - August 11 at 7:02 PM logoAlere (ALR) Reader Attains CE Mark, Submits Delayed 10K (NASDAQ:NUVA) - August 11 at 9:47 AM
News IconNuVasive wins CMS add-on payment for Magec growth mod system (NASDAQ:NUVA) - August 6 at 9:23 AM logoNuVasive Inc. (NUVA) Hits New 52-week High During August 01 Session - (NASDAQ:NUVA) - August 4 at 6:57 PM logoNuVasive, Inc. Is Taking Market Share and the CEO Isn't Afraid to Tout It - Motley Fool (NASDAQ:NUVA) - August 4 at 6:57 PM logoOpen house for Dayton-area company hiring 200 (NASDAQ:NUVA) - August 4 at 6:57 PM


NuVasive (NASDAQ:NUVA) Chart for Sunday, September, 25, 2016

Last Updated on 9/25/2016 by Staff